Harrow Health renames to Harrow, Inc., focusing on eyecare pharmaceuticals

HARROW, INC.

Name change from Harrow Health, Inc. to Harrow, Inc. effective September 29, 2023.
Reflects exclusive focus on U.S. ophthalmic pharmaceutical market as part of 5-year strategic plan.
Stockholders not required to approve; rights unchanged.

item 5.03 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

HARROW, INC.: Amended and restated bylaws solely to reflect the name change (effective 2023-09-29).

Change: bylaw amendment
Effective: 2023-09-29

Exact text from the filing

On the effective date of the Name Change, the Company also amended and restated its bylaws (the “ Amended and Restated Bylaws ”) solely to reflect the Name Change.

View on SEC.gov

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

HARROW, INC.: Changed corporate name from Harrow Health, Inc. to Harrow, Inc. via certificate of amendment to the amended and restated certificate of incorporation (effective 2023-09-29).

Change: charter amendment
Effective: 2023-09-29

Exact text from the filing

Effective as of September 29, 2023, Harrow Health, Inc. (the “ Company ”) changed its corporate name to Harrow, Inc. (the “ Name Change ”) pursuant to a certificate of amendment to the Company’s amended and restated certificate of incorporation filed with the Secretary of State of the State of Delaware.

View on SEC.gov

188 governance changes filed in the last 30 days. Browse all governance changes →

HARROW, INC. filing history →

Source: SEC EDGAR

accession 0001493152-23-034832

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.